Arcturus TherapeuticsARCT
那斯達克 · USD
12.30
+0.09
(+0.74%)
收盤 08/02 03:57 (UTC+8)
盤後
0
0
(0%)
08/02 03:57 (UTC+8)
Arcturus TherapeuticsARCT
12.30
+0.09
(+0.74%)
財務數據
損益表
- 1.60
- 0.80
- 0.11
- 0.45
- 0.31
- 0.38
- 0.50
- 0.42
- 0.23
- 0.29
- 1098.99
- -49.91
- -86.90
- 329.13
- -31.65
- 23.20
- 31.17
- -16.42
- -45.37
- 29.06
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 29,382 | 22,766 | 41,673 | 49,859 | 38,012 | 30,855 | 45,140 | 10,519 | 80,285 | 160,293 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 29,382 | 22,766 | 41,673 | 49,859 | 38,012 | 30,855 | 45,140 | 10,519 | 80,285 | 160,293 |
營業費用 | - | 56,160 | - | - | - | - | 64,454 | 65,893 | 65,530 | 38,841 |
研發費用 | 34,893 | 43,780 | 39,134 | 58,669 | 53,573 | 36,620 | 51,077 | 52,668 | 51,768 | 26,981 |
推銷及管理費用 | 11,315 | 12,380 | 13,276 | 12,316 | 14,851 | 12,507 | 13,377 | 13,225 | 13,762 | 11,860 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -16,826 | -33,394 | -10,737 | -21,126 | -30,412 | -18,272 | -19,314 | -55,374 | 14,755 | 121,452 |
其他收入及費用 | 2,750 | -11,810 | 3,616 | 3,760 | 3,963 | -9,764 | -5,725 | -2,328 | 33,625 | -3,835 |
利息費用 | - | - | - | - | - | - | - | - | - | 420 |
稅前純益 | -14,076 | -30,009 | -7,121 | -17,366 | -26,449 | -11,445 | -15,329 | -51,973 | 50,857 | 118,642 |
所得稅 | - | -4 | -218 | -150 | 368 | 262 | 893 | 577 | 103 | 1,295 |
稅後純益 | -14,076 | -30,005 | -6,903 | -17,216 | -26,817 | -11,707 | -16,222 | -52,550 | 50,754 | 117,347 |
基本每股稅後盈餘(元) | -0.52 | -1.11 | -0.26 | -0.64 | -1.00 | -0.32 | -0.61 | -1.98 | 1.91 | 4.43 |
稀釋每股稅後盈餘(元) | -0.52 | -1.11 | -0.25 | -0.64 | -1.00 | -0.44 | -0.61 | -1.94 | 1.87 | 4.44 |
基本平均股數(千股) | 27107.00 | 27000.00 | 27062.00 | 26967.00 | 26879.00 | 26628.00 | 26574.00 | 26563.00 | 26555.00 | 26508.00 |
稀釋平均股數(千股) | 27107.00 | 27000.00 | 27062.00 | 26967.00 | 26879.00 | 26628.00 | 26574.00 | 26563.00 | 27149.00 | 27080.00 |
還原基本每股稅後盈餘(元) | -0.52 | -1.11 | -0.26 | -0.64 | -1.00 | -0.32 | -0.61 | -1.98 | 1.91 | 4.43 |
還原稀釋每股稅後盈餘(元) | -0.52 | -1.11 | -0.25 | -0.64 | -1.00 | -0.44 | -0.61 | -1.94 | 1.87 | 4.44 |
還原基本平均股數(千股) | 27,107 | 27,000 | 27,062 | 26,967 | 26,879 | 26,628 | 26,574 | 26,563 | 26,555 | 26,508 |
還原稀釋平均股數(千股) | 27,107 | 27,000 | 27,062 | 26,967 | 26,879 | 26,628 | 26,574 | 26,563 | 27,149 | 27,080 |
EBITDA(千元) | -13,275 | -29,190 | -6,209 | -16,457 | -25,545 | -10,630 | -14,502 | -51,236 | 51,435 | 119,613 |